To amend title 5, United States Code, to provide that judicial review under the Administrative Procedure Act does not include any evidence that the court determines is not the product of reliable scientific principles and methods.
Summary
HR9277 is a procedural bill at the earliest legislative stage that would amend the Administrative Procedure Act to restrict judicial review to evidence based on reliable scientific principles and methods. It authorizes no funding, creates no spending programs, and has no direct market impact. No publicly traded companies are directly affected by this bill's current form.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9277 is in the earliest procedural stage with no funding or market mechanism.
- 2.The bill affects federal court evidence standards, not corporate operations or spending.
- 3.No publicly traded companies face direct financial exposure from this proposal.
Market Implications
There are no market implications from this bill. It authorizes no funds, affects no sector, and creates no obligations for any publicly traded company. Investors should monitor whether the bill advances to committee hearings where specific industries might later seek exemptions or inclusions, but at present it is a procedural non-event.
Full Analysis
On June 11, 2026, Representative Hageman introduced HR9277, which was referred to the House Committee on the Judiciary. The bill proposes to amend title 5, United States Code, to prohibit courts from considering evidence in Administrative Procedure Act judicial reviews that the court determines is not the product of reliable scientific principles and methods. This is an early-stage legislative proposal with no funding authorization, no specific appropriation, and no direct corporate beneficiaries or obligations. The bill is one of three actions recorded — all occurring on the same day (introduction and referral). There is no companion bill, committee report, amendment data, or markup scheduled. The legislative path remaining is substantial: committee consideration, potential amendment, floor votes in both chambers, and Presidential action. Given the bill's focus on judicial evidence standards rather than any market-facing regulatory program, it does not directly affect any publicly traded company's revenue, costs, or competitive position. No tickers meet the causal chain confidence threshold for inclusion.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
DELL FEDERAL SYSTEMS L.P: $1.0B Department of Veterans Affairs Contract
FERMI FORWARD DISCOVERY GROUP, LLC: $2.4B Department of Energy Contract
FERMI FORWARD DISCOVERY GROUP, LLC: $2.4B Department of Energy Contract
HII MISSION TECHNOLOGIES CORP: $579M General Services Administration Contract
HII MISSION TECHNOLOGIES CORP: $579M General Services Administration Contract
VERTEX AEROSPACE LLC: $513M General Services Administration Contract
Secure America Act
8-K: Nakamoto Inc. — Obligation Acceleration
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
National Security Presidential Memorandum/NSPM-12
This memorandum rescinds previous national security directives and re-establishes the Committee on National Security Systems (CNSS) to enforce baseline cybersecurity standards across all National Security Systems (NSS) operated by the Department of War, Intelligence Community, and Federal Civilian Executive Branch agencies. It creates binding directives and complementary standards that must meet or exceed NIST guidelines, empowers the NSA Director as the National Manager to issue emergency directives and cryptography requirements, and holds agency heads accountable through government-wide oversight.
National Security Presidential Memorandum/NSPM-11
This memorandum directs the national security enterprise (including the Department of War, intelligence agencies, and others) to accelerate the adoption, adaptation, and assurance of AI technologies for military and intelligence missions. It mandates updates to DOD Directive 3000.09 on autonomous weapons within 90 days, requires termination of contracts with companies that repeatedly violate policy (e.g., by enabling adversary control or embedding bias), and emphasizes supply chain resilience and multi-vendor sourcing to avoid single-vendor dependencies.
Strengthening Customs Enforcement
This executive order directs the Secretary of Homeland Security to revise customs enforcement regulations within 180 days, requiring importers of record (IORs) to maintain minimum tangible domestic assets or bonding, disclose ownership and business affiliations, and maintain good standing with CBP. It prohibits foreign IORs from filing informal entries for low-value articles and imposes additional bonding and CTPAT validation requirements for foreign IORs on formal entries, aiming to enhance compliance and revenue collection.